Corrigendum: X-ray Phase Contrast Tomography Serves Preclinical Investigation of Neurodegenerative Diseases

Front Neurosci. 2021 Feb 17:15:657368. doi: 10.3389/fnins.2021.657368. eCollection 2021.

¹ TomaLab, Institute of Nanotechnology, CNR, Rome, Italy.
² Dipartimento di Fisica, Università della Calabria, Rende, Italy.
³ Dipartimento di Morfogenesi e Ingegneria Tissutale, Sapienza Università di Roma, Rome, Italy.
⁴ Swiss Light Source, Paul Scherrer Institut X-ray Tomography Group, Villigen, Switzerland.
⁵ Department of Neurosciences, Rehabilitation, Ophthalmology and Maternal-Fetal Medicine (DINOGMI), University of Genoa, Genoa, Italy.
⁶ Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
⁷ Institute of Nanotechnology, CNR, Università del Salento, Lecce, Italy.
⁸ Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Abstract

[This corrects the article DOI: 10.3389/fnins.2020.584161.].

Keywords: 3D imaging; Alzheimer's disease; X-ray phase contrast tomography; multiple sclerosis; preclinical disease models.